Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/38951
Title: | Health-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refractory classical Hodgkin lymphoma (R/R cHL) |
Authors: | ZINZANI, P. L.; RAMCHANDREN, R.; SANTORO, A.; PASZKIEWICZ-KOZIK, E.; GASIOROWSKI, R.; JOHNSON, N. A.; OLIVEIRA, J. S. R. de; BUCCHERI, V.; PERINI, G. F.; DICKINSON, M.; MCDONALD, A.; OZCAN, M.; SEKIGUCHI, N.; RAUT, M.; ZHU, Y.; NAHAR, A.; MARINELLO, P.; KURUVILLA, J. |
Citation: | ANNALS OF ONCOLOGY, v.31, suppl.4, p.S649-S649, 2020 |
Appears in Collections: | Comunicações em Eventos - HC/ICHC |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.